Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients.
Zamorano, L. 1; Juan, C. 1; Fernandez-Olmos, A. 2; Ge, Y. 3; Canton, R. 2; Oliver, A. 1
[Article] Clinical Microbiology & Infection. 16(9):1482-1487, September 2010.

(Format: HTML, PDF)